Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002938888 | SCV003270451 | likely benign | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004067247 | SCV003727775 | uncertain significance | not specified | 2021-10-26 | criteria provided, single submitter | clinical testing | The c.215A>G (p.Y72C) alteration is located in exon 4 (coding exon 3) of the BLVRA gene. This alteration results from a A to G substitution at nucleotide position 215, causing the tyrosine (Y) at amino acid position 72 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |